These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8180264)

  • 1. Long-term surveillance of HIV, HBV, and HCV infected patients.
    Shapiro A
    Ann Hematol; 1994; 68 Suppl 3():S87-8. PubMed ID: 8180264
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety of immune globulins.
    Tepper M; Gully P
    Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy about coagulation products.
    Sumner M; Suiter T
    Am J Health Syst Pharm; 2001 May; 58(9):811-2; author reply 812-3. PubMed ID: 11351924
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral safety issues: plasma-derived factor VIII.
    Berntorp E
    Ann Hematol; 1994; 68 Suppl 3():S35-6. PubMed ID: 8180256
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of medical and social history as prescreening to eliminate cornea donors at risk of having hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV).
    Davis AR
    Cornea; 1998 Jul; 17(4):457-8. PubMed ID: 9676925
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance snapshot: service members with hepatitis B, hepatitis C, and HIV-1, active component, U.S. Armed Forces.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2011 Aug; 18(8):23. PubMed ID: 21879788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections with HBV, HCV and HIV in patients admitted to the neurosurgical department of a teaching hospital.
    Gańczak M; Szych Z
    Neurol Neurochir Pol; 2008; 42(3):231-7. PubMed ID: 18651329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV, HBV and HCV: new developments related to transfusion safety.
    Busch MP
    Vox Sang; 2000; 78 Suppl 2():253-6. PubMed ID: 10938963
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty?
    Winkelmann M; Sorrentino JN; Klein M; Macke C; Mommsen P; Brand S; Schröter C; Krettek C; Zeckey C
    Orthop Traumatol Surg Res; 2016 Jun; 102(4):513-6. PubMed ID: 27062330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HCV, HBV and HIV infections: risk for surgeon and staff. Results and consequences of routine screening in emergency patients].
    Dresing K; Pouwels C; Bonsack S; Oellerich M; Schwörer H; Uy A; Stürmer KM
    Chirurg; 2003 Nov; 74(11):1026-33. PubMed ID: 14605720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
    Soldan K; Barbara JA; Ramsay ME; Hall AJ
    Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate.
    Hollinger FB; Dolana G; Thomas W; Gyorkey F
    J Infect Dis; 1984 Aug; 150(2):250-62. PubMed ID: 6432922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma concentrates of factor VIII. Where are we?].
    Vicente V
    Sangre (Barc); 1989 Feb; 34(1):1-3. PubMed ID: 2496481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital].
    Gańczak M; Bohatyrewicz A; Szych Z; Białecki P
    Chir Narzadow Ruchu Ortop Pol; 2008; 73(2):83-8. PubMed ID: 18846999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
    Tripathi AK; Khanna M; Gupta N; Chandra M
    J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present status of infectious diseases transmitted by blood transfusion and the preventive measures].
    Shimoyama T
    Masui; 1999; 48 Suppl():S33-40. PubMed ID: 10785958
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of HBV, HCV and HIV injection in a population of Polish orthopedic surgeons].
    Gańczak M; Milona M; Szych Z; Szechter-Grycewicz A; Bohatyrewicz A
    Chir Narzadow Ruchu Ortop Pol; 2006; 71(1):67-72. PubMed ID: 17128777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.